Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expression and prognostic relevance of MUC1 in stage IB non-small cell lung cancer
Dongrong Situ, Jian Wang, Yun Ma, et al.
Medical Oncology (2010) Vol. 28, Iss. S1, pp. 596-604
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Mechanisms of resistance to CAR T cell therapy
Nirali N. Shah, Terry J. Fry
Nature Reviews Clinical Oncology (2019)
Open Access | Times Cited: 845
The Role of MUC1 in Renal Cell Carcinoma
Martina Milella, Monica Rutigliano, Francesco Lasorsa, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 315-315
Open Access | Times Cited: 34
Mucins in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Implications
Imayavaramban Lakshmanan, Moorthy P. Ponnusamy, Muzafar A. Macha, et al.
Journal of Thoracic Oncology (2014) Vol. 10, Iss. 1, pp. 19-27
Open Access | Times Cited: 132
PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells
Xinru Wei, Yunxin Lai, Jin Li, et al.
OncoImmunology (2017) Vol. 6, Iss. 3, pp. e1284722-e1284722
Open Access | Times Cited: 115
MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer
Audrey Bouillez, Hasan Rajabi, C Jin, et al.
Oncogene (2017) Vol. 36, Iss. 28, pp. 4037-4046
Open Access | Times Cited: 108
Driving CARs on the uneven road of antigen heterogeneity in solid tumors
Nan Chen, Xiaoyu Li, Navin K. Chintala, et al.
Current Opinion in Immunology (2018) Vol. 51, pp. 103-110
Open Access | Times Cited: 107
Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses
Paul Mitchell, N. Thatcher, Mark A. Socinski, et al.
Annals of Oncology (2015) Vol. 26, Iss. 6, pp. 1134-1142
Open Access | Times Cited: 94
Antigen loss following CAR‐T cell therapy: Mechanisms, implications, and potential solutions
Archana Mishra, Rituparna Maiti, Prafull Mohan, et al.
European Journal Of Haematology (2023) Vol. 112, Iss. 2, pp. 211-222
Open Access | Times Cited: 24
Molecular Stratification and Treatment Monitoring of Lung Cancer Using a Small Extracellular Vesicle-Activated Nanocavity Architecture
Junrong Li, Meiqin Li, Alain Wuethrich, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 19, pp. 7651-7660
Closed Access | Times Cited: 15
MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma
Hongyu Xu, Zedong Du, Zhihui Li, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 12
Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas
Audrey Bouillez, Hasan Rajabi, Sean P. Pitroda, et al.
Cancer Research (2016) Vol. 76, Iss. 6, pp. 1538-1548
Open Access | Times Cited: 81
Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer
Zhongqing Chen, Huang Ling-sha, Bo Zhu
Disease Markers (2018) Vol. 2018, pp. 1-7
Open Access | Times Cited: 81
CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment
Bin Liu, Ali Saber, Hidde J. Haisma
Drug Discovery Today (2019) Vol. 24, Iss. 4, pp. 955-970
Open Access | Times Cited: 65
The role of mucin 1 in respiratory diseases
Beatriz Ballester, Javier Milara, Julio Cortijo
European Respiratory Review (2021) Vol. 30, Iss. 159, pp. 200149-200149
Open Access | Times Cited: 44
Expression of MUC1 in different tumours and its clinical significance (Review)
Yue Lan, Weihua Ni, Guixiang Tai
Molecular and Clinical Oncology (2022) Vol. 17, Iss. 6
Open Access | Times Cited: 32
Immunotherapy for Non-small Cell Lung Cancer: Novel Approaches to Improve Patient Outcome
Frances A. Shepherd, Jean‐Yves Douillard, George R. Blumenschein
Journal of Thoracic Oncology (2011) Vol. 6, Iss. 10, pp. 1763-1773
Open Access | Times Cited: 72
Prognostic Significance of Mucin Antigen MUC1 in Various Human Epithelial Cancers
Feng Xu, Fuquan Liu, Hongwei Zhao, et al.
Medicine (2015) Vol. 94, Iss. 50, pp. e2286-e2286
Open Access | Times Cited: 62
MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells
Akriti Kharbanda, Hasan Rajabi, Caining Jin, et al.
Oncotarget (2014) Vol. 5, Iss. 19, pp. 8893-8905
Open Access | Times Cited: 59
Molecular Pathways: Mucins and Drug Delivery in Cancer
Chinthalapally V. Rao, Naveena B. Janakiram, Altaf Mohammed
Clinical Cancer Research (2016) Vol. 23, Iss. 6, pp. 1373-1378
Open Access | Times Cited: 49
MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer
Audrey Bouillez, Dennis O. Adeegbe, Caining Jin, et al.
OncoImmunology (2017) Vol. 6, Iss. 9, pp. e1338998-e1338998
Open Access | Times Cited: 49
Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer
Aying Wang, Tangfeng Lv, Yong Song
Cellular Immunology (2023) Vol. 391-392, pp. 104760-104760
Closed Access | Times Cited: 15
Mucin 1-mediated chemo-resistance in lung cancer cells
Sun-Young Ham, Il Keun Kwon, Y BAK, et al.
Oncogenesis (2016) Vol. 5, Iss. 1, pp. e185-e185
Open Access | Times Cited: 47
Cigarette smoke disrupts the integrity of airway adherens junctions through the aberrant interaction of p120‐catenin with the cytoplasmic tail of MUC1
Lili Zhang, Marianne Gallup, Lorna Zlock, et al.
The Journal of Pathology (2012) Vol. 229, Iss. 1, pp. 74-86
Open Access | Times Cited: 44
Pivotal role of MUC1 glycosylation by cigarette smoke in modulating disruption of airway adherens junctions in vitro
Lili Zhang, Marianne Gallup, Lorna Zlock, et al.
The Journal of Pathology (2014) Vol. 234, Iss. 1, pp. 60-73
Open Access | Times Cited: 39
Beyond Carcinoembryonic Antigens: The Role of CA-125 and CA-199 in Predicting Prognosis of Lung Adenocarcinoma
Yen-Kun Ko, Yiting Liu, Chia-Yu Tai, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1517-1517
Open Access
Page 1 - Next Page

Scroll to top